ClinConnect ClinConnect Logo
Search / Trial NCT05017519

Epidemiology and Household Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus

Launched by MACKAY MEMORIAL HOSPITAL · Aug 17, 2021

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Streptococcus Pneumoniae Respiratory Syncytial Virus Household Based

ClinConnect Summary

This clinical trial is studying how two viruses, Respiratory Syncytial Virus (RSV) and Streptococcus pneumoniae, spread within households, particularly focusing on young children and older adults. The goal is to understand how these infections are transmitted when family members live together and to see if there is a connection between the two viruses.

To participate, families need to have a baby under 5 months old who was born at Mackay Children's Hospital and is currently healthy. Family members living with the baby, including siblings aged 2-5, parents, and grandparents over 65, can also join. Participants will be asked to sign a consent form and use a messaging app called LINE to help keep track of the study. If you have a baby older than 5 months or certain health issues, or if family members do not live with the baby or refuse to participate, you won't be eligible for this trial. This is a great opportunity to help researchers learn more about these infections and how they spread, which can ultimately improve health outcomes for everyone.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Indicator case: Babies under 5 months of age were born in Mackay Children's Hospital and had no acute respiratory infection-like symptoms that required medical intervention when they agreed to participate in the trial.
  • Family members: family members living with the Indicator case, including 2-5 years old siblings, parents and grandparents over 65 years old.
  • Willing to sign the informed consent form and agree to join the official LINE account to receive research tracking.
  • Exclusion Criteria:
  • Babies older than 5 months
  • Co-morbid medical conditions of the baby such as chronic lung disease, cyanotic congenital heart disease, neuromuscular disease and a primary immunodeficiency.
  • Family members who do not live with the Indicator case
  • Family with grandparents younger than 65 years old
  • Someone living with family members refuses to participate in the research.
  • Unwilling to sign informed consent form or refuse to join the official LINE account to receive tracking.

About Mackay Memorial Hospital

Mackay Memorial Hospital is a leading healthcare institution dedicated to advancing medical science through innovative clinical research. With a commitment to patient-centered care, the hospital actively sponsors and conducts clinical trials across various therapeutic areas, aiming to develop new treatment options and improve health outcomes. Boasting a team of experienced researchers and healthcare professionals, Mackay Memorial Hospital adheres to rigorous ethical standards and regulatory guidelines, ensuring the safety and well-being of participants while contributing to the global body of medical knowledge. Its collaborative approach fosters partnerships with academic institutions and industry leaders, positioning it as a key player in the advancement of healthcare solutions.

Locations

Patients applied

0 patients applied

Trial Officials

Hsin Chi, Doctor

Principal Investigator

Mackay Children's Hospital in Taiwan

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials